Skip to content

Author

Matthew A. Miller

We have 1 of 37 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Long-Acting Lipoglycopeptide Treatment of Invasive Gram-Positive Infections

A narrative review, including the pharmacological characteristics of dalbavancin (DAL) and oritavancin (ORI), the only currently available laLGPs, as well as their approved and “off-label” use reported in the literature to date.

Madison E. Salam, D. Chastain, Douglas N. Fish et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.